Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mark T. Fleming, MD
Virginia Oncology Associates/US Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
55 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hematology Oncology Associates
Phoenix, Arizona, United States
- Northern Az Hematology & Oncology Assoc
Sedona, Arizona, United States
- Rocky Mountain Cancer Center-Midtown
Denver, Colorado, United States
- Melbourne Internal Medicine Associates
Melbourne, Florida, United States
- Florida Cancer Institute - New Hope
New Port Richey, Florida, United States
- Ocala Oncology Center
Ocala, Florida, United States
- Cancer Centers of Florida, P.A.
Ocoee, Florida, United States
- Cancer Care & Hematology Specialists of Chicagoland
Niles, Illinois, United States
- Central Indiana Cancer Centers
Indianapolis, Indiana, United States
- Hope Center
Terre Haute, Indiana, United States
- Minnesota Oncology Hematology, P.A.
Minneapolis, Minnesota, United States
- Missouri Cancer Associates
Columbia, Missouri, United States
- St. Joseph Oncology, Inc.
Saint Joseph, Missouri, United States
- Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, United States
- Nh Oncology-Hematology Pa
Hooksett, New Hampshire, United States
- Hematology-Oncology Associates of Nnj, P
Morristown, New Jersey, United States
- Albany Medical Cancer Center
Albany, New York, United States
- Interlakes Oncology Hematology, Pc
Rochester, New York, United States
- Cancer Centers of North Carolina
Raleigh, North Carolina, United States
- Greater Dayton Cancer Center
Kettering, Ohio, United States
- Willamette Valley Cancer Center
Eugene, Oregon, United States
- Oregon Health & Science University
Portland, Oregon, United States
- Cancer Centers of the Carolinas
Greenville, South Carolina, United States
- Texas Oncology, P.A. -Amarillo
Amarillo, Texas, United States
- Texas Oncology, P.A.
Arlington, Texas, United States
- Texas Oncology - Central Austin Cancer Center
Austin, Texas, United States
- Mamie Mcfaddin Ward Cancer Center
Beaumont, Texas, United States
- Methodist Charlton Cancer Ctr.
Dallas, Texas, United States
- Texas Cancer Center at Medical City
Dallas, Texas, United States
- Texas Oncology, P.A.
Dallas, Texas, United States
- Texas Oncology, P.A.
Dallas, Texas, United States
- Texas Cancer Center
Denton, Texas, United States
- El Paso Cancer Treatment Ctr
El Paso, Texas, United States
- Texas Oncology, P.A.
Fort Worth, Texas, United States
- Texas Oncology, P.A
Garland, Texas, United States
- Longview Cancer Center
Longview, Texas, United States
- South Texas Cancer Center - Mcallen
McAllen, Texas, United States
- Texas Cancer Center of Mesquite
Mesquite, Texas, United States
- Allison Cancer Center
Midland, Texas, United States
- Texas Oncology - Odessa
Odessa, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2008
- Primary completion
- 31 Mar 2011
- Completion
- 30 Jun 2011
- Last update posted
- 9 Dec 2016
- Registered enrollment
- 115
- Registry id
- NCT00661492
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.